These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25727963)

  • 21. Role of 5-HT receptor antagonists in mediating intracavernous pressure response induced by fluvoxamine in conscious rats.
    Aizawa N; Ishizuka O; Ogawa T; Mizusawa H; Igawa Y; Nishizawa O
    J Sex Med; 2007 Jul; 4(4 Pt 2):1108-16. PubMed ID: 17627723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex.
    Ago Y; Koyama Y; Baba A; Matsuda T
    Neuropharmacology; 2003 Dec; 45(8):1050-6. PubMed ID: 14614948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M; Somboonthum P; Nishihara B; Koyama Y; Hashimoto H; Baba A; Matsuda T
    Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice.
    Harasawa T; Ago Y; Itoh S; Baba A; Matsuda T
    Behav Pharmacol; 2006 Nov; 17(7):637-40. PubMed ID: 17021397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prelimbic cortex 5-HT1A and 5-HT2C receptors are involved in the hypophagic effects caused by fluoxetine in fasted rats.
    Stanquini LA; Resstel LB; Corrêa FM; Joca SR; Scopinho AA
    Pharmacol Biochem Behav; 2015 Sep; 136():31-8. PubMed ID: 26143050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors.
    Kaneko F; Kawahara Y; Kishikawa Y; Hanada Y; Yamada M; Kakuma T; Kawahara H; Nishi A
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27029212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens.
    Andrews CM; Kung HF; Lucki I
    Eur J Pharmacol; 2005 Jan; 508(1-3):123-30. PubMed ID: 15680262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
    J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action.
    Díaz-Mataix L; Scorza MC; Bortolozzi A; Toth M; Celada P; Artigas F
    J Neurosci; 2005 Nov; 25(47):10831-43. PubMed ID: 16306396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S; Westlin D; Bengtsson HJ
    Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
    Ferrés-Coy A; Santana N; Castañé A; Cortés R; Carmona MC; Toth M; Montefeltro A; Artigas F; Bortolozzi A
    Psychopharmacology (Berl); 2013 Jan; 225(1):61-74. PubMed ID: 22820867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical and behavioral studies on the 5-HT
    Woźniak M; Gołembiowska K; Noworyta-Sokołowska K; Acher F; Cieślik P; Kusek M; Tokarski K; Pilc A; Wierońska JM
    Neuropharmacology; 2017 Mar; 115():149-165. PubMed ID: 27465045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
    Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
    J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
    Newman ME; Shalom G; Ran A; Gur E; Van de Kar LD
    Eur J Pharmacol; 2004 Feb; 486(1):25-30. PubMed ID: 14751404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE; Haddjeri N; Debonnel G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.